ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cellectar Receives FTD for Diffuse Large B-Cell Lymphoma Treatment
July 10, 2019Drug conjugate, CL131, delivers cytotoxic radiation directly and selectively to cancer cells. -
Passage Bio receives $115m in funding to address CNS diseases
February 18, 2019Gene therapy company Passage Bio has launched in the US with $115.5m series A funding to develop AAV-delivered therapies for the treatment of rare monogenic central nervous system (CNS) disorders..... -
FDA Grants Orphan-drug Designation for LMTX in Frontotemporal Dementia
December 11, 2018TauRx announced the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to LMTX for the "treatment of frontotemporal dementia.” The term Frontotemporal Dementia (FTD) covers.....
Pharma Sources Insight January 2025
